3FFZ image
Deposition Date 2008-12-04
Release Date 2008-12-16
Last Version Date 2024-10-30
Entry Detail
PDB ID:
3FFZ
Keywords:
Title:
Domain organization in Clostridium butulinum neurotoxin type E is unique: Its implication in faster translocation
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.30
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Botulinum neurotoxin type E
Gene (Uniprot):botE
Chain IDs:A, B
Chain Length:1252
Number of Molecules:2
Biological Source:Clostridium botulinum
Primary Citation
Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.
J.Mol.Biol. 386 233 245 (2009)
PMID: 19118561 DOI: 10.1016/j.jmb.2008.12.027

Abstact

Clostridium botulinum produces seven antigenically distinct neurotoxins [C. botulinum neurotoxins (BoNTs) A-G] sharing a significant sequence homology. Based on sequence and functional similarity, it was believed that their three-dimensional structures will also be similar. Indeed, the crystal structures of BoNTs A and B exhibit similar fold and domain association where the translocation domain is flanked on either side by binding and catalytic domains. Here, we report the crystal structure of BoNT E holotoxin and show that the domain association is different and unique, although the individual domains are similar to those of BoNTs A and B. In BoNT E, both the binding domain and the catalytic domain are on the same side of the translocation domain, and all three have mutual interfaces. This unique association may have an effect on the rate of translocation, with the molecule strategically positioned in the vesicle for quick entry into cytosol. Botulism, the disease caused by BoNT E, sets in faster than any other serotype because of its speedy internalization and translocation, and the present structure offers a credible explanation. We propose that the translocation domain in other BoNTs follows a two-step process to attain translocation-competent conformation as in BoNT E. We also suggest that this translocation-competent conformation in BoNT E is a probable reason for its faster toxic rate compared to BoNT A. However, this needs further experimental elucidation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures